Published in Am J Dis Child on March 01, 1972
Immunization today--a review. Can Med Assoc J (1973) 1.37
Assessment of signs of influenza illness in the ferret model. J Virol Methods (1989) 3.07
Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis (1989) 2.21
Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis (1986) 1.68
Encephalitis associated with erythema infectiosum. J Pediatr (1970) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus. J Virol (1988) 1.49
A human recombinant haemoglobin designed for use as a blood substitute. Nature (1992) 1.42
Transmission of rubella from newborns. A controlled study among young adult women and report of an unusual case. Am J Dis Child (1965) 1.39
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis (1990) 1.32
Pseudovitelliform macular degeneration. Arch Ophthalmol (1977) 1.30
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol (1975) 1.28
A study of erythema infectiosum: recovery of rubella virus and echovirus-12. Pediatrics (1972) 1.27
Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis (1991) 1.23
A seroepidemiologic study of a measles epidemic in a highly immunized population. Am J Epidemiol (1972) 1.21
Evidence for natural reassortants of human rotaviruses belonging to different genogroups. J Virol (1990) 1.20
Plasma cholesterol and triglyceride levels in 6,775 school children, ages 6--17. Metabolism (1977) 1.18
Adolescents and sexually transmitted diseases: an expanding problem. Introduction. J Adolesc Health Care (1985) 1.17
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. Vaccine (1998) 1.12
Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis (1991) 1.11
Rubella-vaccinated students. Follow-up in a public school system. JAMA (1978) 1.10
Measles IgM response during reinfection of previously vaccinated children. J Pediatr (1973) 1.10
Rubella vaccine evaluation in a public school system. Am J Dis Child (1969) 1.09
Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope. Proc Natl Acad Sci U S A (1992) 1.05
Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05
Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res (1989) 1.04
Local and systemic antibody response to rotavirus WC3 vaccine in adult volunteers. Antiviral Res (1989) 1.02
Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child (1972) 1.02
Screening hospital patients for hepatitis B surface antigen. Am J Clin Pathol (1977) 1.01
Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus. J Virol (1990) 0.98
Studies on congenital rubella. Preliminary results on the frequency and significance of presence of rubella virus in the newborn and the effect of gamma-globulin in preventing congenital rubella. Am J Dis Child (1965) 0.98
Rubella: recent laboratory and clinical advances. Prog Med Virol (1966) 0.98
Rubella antibody levels in juvenile rheumatoid arthritis. Ann Rheum Dis (1975) 0.97
Letter: Self-induced subcutaneous emphysema in an adolescent. J Pediatr (1976) 0.97
Protection of adults rechallenged with a human rotavirus. J Infect Dis (1990) 0.97
Screening asymptomatic adolescent males for chlamydia. J Adolesc Health Care (1990) 0.97
Fatal viral encephalitis in children with X-linked hypogammaglobulinemia. Am J Dis Child (1973) 0.96
Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. Am J Dis Child (1975) 0.96
Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees. Am J Dis Child (1969) 0.95
Rubella: studies on the natural disease. The significance of antibody status and communicability among young women. Am J Dis Child (1965) 0.94
Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis (1992) 0.94
Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis (1990) 0.93
Effect of a patient management system on outcomes of total hip and knee arthroplasty. Clin Orthop Relat Res (1997) 0.91
Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health (1996) 0.91
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
Cell-mediated immunity in humans during viral infection: dermal hypersensitivity and in vitro lymphocyte proliferation during mild viral respiratory infections. Infect Immun (1974) 0.91
Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90
Chlamydia trachomatis cervical infections in female adolescents. J Pediatr (1981) 0.89
Experimental rubella. Clinical and laboratory findings. Arch Intern Med (1965) 0.89
Lipids, lipoproteins, and sexual maturation during adolescence: the Princeton maturation study. Metabolism (1979) 0.88
Influenza in ferrets and guinea pigs: effect on cell-mediated immunity. Infect Immun (1978) 0.88
Bloom's syndrome. Am J Dis Child (1968) 0.87
Induction and persistence of local rotavirus antibodies in relation to serum antibodies. J Med Virol (1989) 0.87
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteers. Vaccine (2001) 0.86
Problems with contraception in adolescents. The successful use of an intrauterine device. Clin Pediatr (Phila) (1971) 0.86
Challenge with rubella virus after loss of detectable vaccine-induced antibody. Rev Infect Dis (1985) 0.86
The management of adolescent pregnancy and prevention of repeat pregnancies. HSMHA Health Rep (1971) 0.85
Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection? Arch Intern Med (1978) 0.85
Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella. Am J Dis Child (1969) 0.85
Evaluation of a live, attenuated recombinant influenza vaccine in high school children. Infect Immun (1975) 0.85
Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV. J Med Virol (1991) 0.85
Lipids in schoolchildren 6 to 17 years of age: upper normal limits. Pediatrics (1977) 0.85
Low-level dynamic exercises for earlier cardiac rehabilitation: aerobic and hemodynamic responses. Arch Phys Med Rehabil (1976) 0.84
Experimental rubella in pregnant rhesus monkeys. J Infect Dis (1966) 0.83
Detection of viremia by a one step polymerase chain reaction method in hepatitis C virus infection. Virus Res (1993) 0.82
Maximal cardiac output during upright exercise: approximate normal standards and variations with coronary heart disease. Am J Cardiol (1980) 0.82
Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus. J Med Virol (1990) 0.82
Divergent effects of diltiazem in patients with exertional angina. Am J Cardiol (1982) 0.82
Studies of echovirus-12 in volunteers: determination of minimal infectious dose and the effect of previous infection on infectious dose. J Infect Dis (1984) 0.82
Herpesvirus hominis type 2 meningoencephalitis following renal transplantation. Am J Med (1976) 0.82
Rubella control. Am J Dis Child (1971) 0.82
Comparison of class and subclass antibody response to live and UV-inactivated RSV administered intranasally in mice. J Med Virol (1991) 0.82
Rubella vaccinees in a public school system: a four and one-half-year follow-up. Am J Dis Child (1974) 0.82
Reye's syndrome. Annu Rev Med (1976) 0.81
Salivary antibody titers in adults challenged with a human rotavirus. J Med Virol (1992) 0.81
Oral ribavirin treatment of influenza A and B. Antimicrob Agents Chemother (1987) 0.80
Influenza-specific ELISA IgA and IgG predict severity of influenza disease in subjects prescreened with hemagglutination inhibition. Antiviral Res (1990) 0.80
The reproductive adolescent. Pediatr Clin North Am (1973) 0.80
Salicylate intoxication and influenza in ferrets. Pediatr Res (1979) 0.80
Rocky Mountain spotted fever in Clermont County, Ohio: description of an endemic focus. Am J Epidemiol (1973) 0.79
Chlorphentermine as an anorexigenic agent in adolescent obesity. Report of its efficacy in a double-blind study of 30 teen-agers. Clin Pediatr (Phila) (1968) 0.79
Follow-up studies of rubella vaccinees at adolescence. J Pediatr (1975) 0.78
Isolation and characterization of mouse nasal lymphocytes. J Immunol Methods (1989) 0.77
Experience with side effects and health risks associated with Norplant implant use in adolescents. Contraception (1995) 0.77
Febrile illness in early infancy associated with ECHO virus infection. J Pediatr (1974) 0.77
Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy. Transplant Proc (1996) 0.76